Cargando…
Rechallenging Fluoropyrimidine-Induced Cardiotoxicity and Neurotoxicity: A Report of Two Cases
Fluoropyrimidines (FP’s) such as fluorouracil (5-FU) and capecitabine are antimetabolites widely used in many solid tumors. FPs side effects are caused mainly by a lack of dihydropyrimidine dehydrogenase (DPD) enzyme. It has been noticed that treatment with infusional regimens of 5-FU is associated...
Autores principales: | Ashish, Sethi, Raj, Moses S, Monga, Dulabh, Finley, Gene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372383/ https://www.ncbi.nlm.nih.gov/pubmed/35971344 http://dx.doi.org/10.7759/cureus.26824 |
Ejemplares similares
-
Rechallenge capecitabine after fluoropyrimidine-induced cardiotoxicity in rectal cancer: A case report
por: Peng, Tao, et al.
Publicado: (2019) -
Epidemiology and Retrospective Analysis in Extrapulmonary Neuroendocrine Carcinoma
por: Sethi, Ashish, et al.
Publicado: (2021) -
Fluoropyrimidine-induced cardiotoxicity
por: Deac, Andrada Larisa, et al.
Publicado: (2020) -
Atypical Hemolytic Uremic Syndrome: Cancer-Induced or Chemotherapy-Induced?
por: Sethi, Ashish, et al.
Publicado: (2021) -
The puzzling clinical presentation of fluoropyrimidines cardiotoxicity
por: Cucciniello, Linda, et al.
Publicado: (2022)